Showing 1 - 4 of 4
Bumrungrad Heart Institute Elevates Global Standards in Cardiac Care
Published on 24/09/2025
» Cardiovascular disease is a silent killer and a worldwide threat. According to the World Health Organization, 17-18 million people die from heart disease annually, accounting for one-third of all deaths. Moreover, heart disease continues to increase in prevalence among younger people with risk factors such as diabetes, high blood pressure, obesity, and a high-stress lifestyle. Bumrungrad International Hospital is committed to ensuring the Heart Institute, a specialised centre of medical excellence, remains equipped to address all forms of heart disease. With cutting-edge technology and a multidisciplinary team of specialist physicians, it delivers safe, effective treatments to help patients regain their quality of life.
Lifetime strategy transforms heart valve disease management
Published on 11/09/2025
» Cardiovascular diseases (CVDs) represent an increasingly significant health concern, especially among individuals under the age of 60. Although CVDs have traditionally been prevalent in older populations due to age-related degeneration, modern lifestyle factors are contributing to earlier onset. Notable risk factors include high-fat diets, physical inactivity, tobacco use, and excessive alcohol consumption, all of which promote the development of obesity, diabetes, hyperlipidaemia, and hypertension at younger ages. Additionally, congenital abnormalities and post-infectious complications play roles in the pathogenesis of cardiovascular disorders. According to the World Heart Federation, cardiovascular diseases, including heart valve disease, constitute the leading cause of global mortality, accounting for more than 20.5 million deaths annually.
Edwards Unveils Breakthrough Valve Repair System in Thailand
Published on 10/06/2025
» Bangkok, June 9, 2025: In an era of continuous advancements in medical technology, Edwards Lifesciences (NYSE: EW), a global leader in patient-focused innovations for structural heart disease, has announced a significant breakthrough with the launch of its Transcatheter Mitral Valve Repair System in Thailand. This system provides a new treatment option for patients suffering from mitral regurgitation (MR), which is one of the most common valvular heart diseases, affecting more than 175 million people worldwide in 2023, as reported by the U.S. National Center for Biotechnology Information (NCBI).
MPs denied access to Thaksin
News, Wassayos Ngamkham and Sukanya Pongpaew, Published on 13/01/2024
» Members of the House committee on police affairs were not allowed to see convicted former prime minister Thaksin Shinawatra during their inspection of the Police General Hospital yesterday.